EU Medicines Agency Panel Issues Positive Opinion on AstraZeneca's Hypertension Drug

MT Newswires · 1d ago
07:00 AM EST, 11/13/2026 (MT Newswires) -- The European Medicines Agency's human medicines committee recommended AstraZeneca's (AZN.L) Baxfendy drug for market authorization, according to a Friday notice. The drug is intended for adults with poorly controlled arterial hypertension despite undergoing treatment with at least two blood pressure-lowering medicines. The positive opinion is based on clinical studies showing significant reductions in systolic and diastolic blood pressure. The drug remains subject to final approval by the European Commission.